Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (65)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rusyn, I.
Right arrow Articles by Thurman, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rusyn, I.
Right arrow Articles by Thurman, R. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1217-1222, Copyright © 1998 by Oxford University Press


ARTICLES

WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes

I Rusyn, H Tsukamoto and RG Thurman
Laboratory of Hepatobiology and Toxicology, University of North Carolina at Chapel Hill, 27599-7365, USA.

Stimulation of cell proliferation caused by peroxisome proliferators was blocked by antibodies against TNF alpha and agents that inactivate Kupffer cells, a rich source of TNF alpha, which supports the hypothesis that Kupffer cells play a pivotal role in peroxisome proliferator-induced hyperplasia. Here, the ability of the very potent peroxisome proliferator WY-14 643 to activate the transcription factor NF-kappaB in rat liver was examined since it is involved in TNF alpha production. Female Sprague-Dawley rats were treated by gavage with WY- 14 643 (100 mg/kg) while control animals were given equivalent doses of vehicle (olive oil). Activation of NF-kappaB in both whole liver, non- parenchymal cells, Kupffer cells and hepatocytes was assessed for up to 36 h using an electrophoretic mobility shift assay. In whole liver, WY- 14 643 transiently increased NF-kappaB binding maximally 3.5-fold in 2- 8 h followed by a steady decline to near control levels at 36 h. As early as 2 h after WY-14 643 treatment, the active form of NF-kappaB was localized predominantly in Kupffer cells with values 20- to 25- times greater than in hepatocytes. In hepatocytes, a small increase in NF-kappaB binding was observed but only 8 h after WY-14 643 administration. Pre-treatment with allopurinol, a xanthine oxidase inhibitor and free radical scavenger, suppressed NF-kappaB activation by WY-14 643 almost completely. It is concluded that NF-kappaB is activated by reactive oxygen species and plays a central role in the mechanism of action of peroxisome proliferators. Moreover, these findings support the hypothesis that Kupffer cells play a pivotal role in peroxisome proliferator-induced hepatocyte proliferation through rapid NF-kappaB activation and subsequent induction of TNF alpha production. TNF alpha from Kupffer cells stimulates growth in parenchymal cells later via mechanisms that also involve NF-kappaB.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
C. G. Woods, A. M. Burns, B. U. Bradford, P. K. Ross, O. Kosyk, J. A. Swenberg, M. L. Cunningham, and I. Rusyn
WY-14,643 Induced Cell Proliferation and Oxidative Stress in Mouse Liver are Independent of NADPH Oxidase
Toxicol. Sci., August 1, 2007; 98(2): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol, June 1, 2007; 35(4): 474 - 494.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Q. Yang, S. Ito, and F. J. Gonzalez
Hepatocyte-restricted constitutive activation of PPAR{alpha} induces hepatoproliferation but not hepatocarcinogenesis
Carcinogenesis, June 1, 2007; 28(6): 1171 - 1177.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig
Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Toxicol. Sci., March 1, 2007; 96(1): 2 - 15.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. F. Cariello, E. H. Romach, H. M. Colton, H. Ni, L. Yoon, J. G. Falls, W. Casey, D. Creech, S. P. Anderson, G. R. Benavides, et al.
Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver
Toxicol. Sci., November 1, 2005; 88(1): 250 - 264.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. M. Elrick, J. A. Kramer, C. L. Alden, E. A. G. Blomme, R. T. Bunch, M. A. Cabonce, S. W. Curtiss, L. D. Kier, K. L. Kolaja, C. P. Rodi, et al.
Differential Display in Rat Livers Treated for 13 Weeks with Phenobarbital Implicates a Role for Metabolic and Oxidative Stress in Nongenotoxic Carcinogenicity
Toxicol Pathol, January 1, 2005; 33(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. C. Cattley
Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis
Toxicol Pathol, February 1, 2004; 32(2_suppl): 6 - 11.
[Abstract] [PDF]


Home page
Mol Cancer ResHome page
M. D. Wheeler, O. M. Smutney, and R. J. Samulski
Secretion of Extracellular Superoxide Dismutase From Muscle Transduced With Recombinant Adenovirus Inhibits the Growth of B16 Melanomas in Mice
Mol. Cancer Res., October 1, 2003; 1(12): 871 - 881.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. A. Kramer, E. A.G. Blomme, R. T. Bunch, J. C. Davila, C. J. Jackson, P. F. Jones, K. L. Kolaja, and S. W. Curtiss
Transcription Profiling Distinguishes Dose-Dependent Effects in the Livers of Rats Treated with Clofibrate
Toxicol Pathol, June 1, 2003; 31(4): 417 - 431.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Wheeler and R. G. Thurman
Up-regulation of CD14 in Liver Caused by Acute Ethanol Involves Oxidant-dependent AP-1 Pathway
J. Biol. Chem., February 28, 2003; 278(10): 8435 - 8441.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. D. Wheeler, O. M. Smutney, J. F. Check, I. Rusyn, R. Schulte-Hermann, and R. G. Thurman
Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G302 - G312.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. M. Siesky, L. M. Kamendulis, and J. E. Klaunig
Hepatic Effects of 2-Butoxyethanol in Rodents
Toxicol. Sci., December 1, 2002; 70(2): 252 - 260.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. L. O'Brien, M. L. Cunningham, B. T. Spear, and H. P. Glauert
Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters
Toxicol. Sci., September 1, 2002; 69(1): 139 - 148.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. G. Fischer, H. P. Glauert, T. Yin, M. L. Sweeney-Reeves, N. Larmonier, and M. C. Black
Moderate Iron Overload Enhances Lipid Peroxidation in Livers of Rats, but Does Not Affect NF-{kappa}B Activation Induced by the Peroxisome Proliferator, Wy-14,643
J. Nutr., September 1, 2002; 132(9): 2525 - 2531.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Hasmall, G. Orphanides, N. James, W. Pennie, K. Hedley, A. Soames, I. Kimber, and R. Roberts
Downregulation of Lactoferrin by PPAR{alpha} Ligands: Role in Perturbation of Hepatocyte Proliferation and Apoptosis
Toxicol. Sci., August 1, 2002; 68(2): 304 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nakatani, N. Tsuboyama-Kasaoka, M. Takahashi, S. Miura, and O. Ezaki
Mechanism for Peroxisome Proliferator-activated Receptor-alpha Activator-induced Up-regulation of UCP2 mRNA in Rodent Hepatocytes
J. Biol. Chem., March 8, 2002; 277(11): 9562 - 9569.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. P. Anderson, C. S. Dunn, R. C. Cattley, and J.C. Corton
Hepatocellular proliferation in response to a peroxisome proliferator does not require TNF{alpha} signaling
Carcinogenesis, November 1, 2001; 22(11): 1843 - 1851.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Cui, H. Kawashima, T. B. Barclay, J. M. Peters, F. J. Gonzalez, E. T. Morgan, and H. W. Strobel
Molecular Cloning and Regulation of Expression of Two Novel Mouse CYP4F Genes: Expression in Peroxisome Proliferator-Activated Receptor alpha -Deficient Mice upon Lipopolysaccharide and Clofibrate Challenges
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 542 - 550.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
M. D. Wheeler, S. Yamashina, M. Froh, I. Rusyn, and R. G. Thurman
Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-{kappa}B activation and cytokine production
J. Leukoc. Biol., April 1, 2001; 69(4): 622 - 630.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
I. Rusyn, M. B. Kadiiska, A. Dikalova, H. Kono, M. Yin, K. Tsuchiya, R. P. Mason, J. M. Peters, F. J. Gonzalez, B. H. Segal, et al.
Phthalates Rapidly Increase Production of Reactive Oxygen Species in Vivo: Role of Kupffer Cells
Mol. Pharmacol., April 1, 2001; 59(4): 744 - 750.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
W. Parzefall, W. Berger, E. Kainzbauer, O. Teufelhofer, R. Schulte-Hermann, and R. G. Thurman
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes
Carcinogenesis, March 1, 2001; 22(3): 519 - 523.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. S. Elangbam, R. D. Tyler, and R. M. Lightfoot
Peroxisome Proliferator-activated Receptors in Atherosclerosis and Inflammation--An Update
Toxicol Pathol, February 1, 2001; 29(2): 224 - 231.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
I. Rusyn, M. F. Denissenko, V. A. Wong, B. E. Butterworth, M. L. Cunningham, P. B. Upton, R. G. Thurman, and J. A. Swenberg
Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency
Carcinogenesis, December 1, 2000; 21(12): 2141 - 2145.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. C. Hasmall, D. A. West, K. Olsen, and R. A. Roberts
Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro
Carcinogenesis, December 1, 2000; 21(12): 2159 - 2165.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. C. Cosulich, N. H. James, M. R.C. Needham, P. P. Newham, K. R. Bundell, and R. A. Roberts
A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin
Carcinogenesis, September 1, 2000; 21(9): 1757 - 1760.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Rusyn, S. Yamashina, B. H. Segal, R. Schoonhoven, S. M. Holland, R. C. Cattley, J. A. Swenberg, and R. G. Thurman
Oxidants from Nicotinamide Adenine Dinucleotide Phosphate Oxidase Are Involved in Triggering Cell Proliferation in the Liver Due to Peroxisome Proliferators
Cancer Res., September 1, 2000; 60(17): 4798 - 4803.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Kono, I. Rusyn, B. U. Bradford, H. D. Connor, R. P. Mason, and R. G. Thurman
Allopurinol Prevents Early Alcohol-Induced Liver Injury in Rats
J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 296 - 303.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
R. T. Miller, S. P. Anderson, J.C. Corton, and R. C. Cattley
Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas
Carcinogenesis, April 1, 2000; 21(4): 647 - 652.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. M. Peters, I. Rusyn, M. L. Rose, F. J. Gonzalez, and R. G. Thurman
Peroxisome proliferator-activated receptor {alpha} is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis
Carcinogenesis, April 1, 2000; 21(4): 823 - 826.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Rusyn, C. A. Bradham, L. Cohn, R. Schoonhoven, J. A. Swenberg, D. A. Brenner, and R. G. Thurman
Corn oil rapidly activates nuclear factor-{kappa}B in hepatic Kupffer cells by oxidant-dependent mechanisms
Carcinogenesis, November 1, 1999; 20(11): 2095 - 2100.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. A. Roberts and I. Kimber
Cytokines in non-genotoxic hepatocarcinogenesis
Carcinogenesis, August 1, 1999; 20(8): 1397 - 1402.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Kroll, S. Kunz, T. Klein, and L. R. Schwarz
Effect of lindane and phenobarbital on cyclooxygenase-2 expression and prostanoid synthesis by Kupffer cells
Carcinogenesis, August 1, 1999; 20(8): 1411 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. R. Hill, S. Clarke, K. Rodgers, B. Thornhill, J. M. Peters, F. J. Gonzalez, and J. M. Gimble
Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia
Infect. Immun., July 1, 1999; 67(7): 3488 - 3493.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. K. Eagon, A. G. Teepe, M. S. Elm, S. D. Tadic, M. J. Epley, B. E. Beiler, H. Shinozuka, and K. N. Rao
Hepatic hyperplasia and cancer in rats: alterations in copper metabolism
Carcinogenesis, June 1, 1999; 20(6): 1091 - 1096.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Chevalier, N Macdonald, and R. Roberts
Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor (alpha) priming and EGF-receptor tyrosine kinase activity
J. Cell Sci., January 12, 1999; 112(24): 4785 - 4791.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
M. L. Rose, C. A. Rivera, B. U. Bradford, L. M. Graves, R. C. Cattley, R. Schoonhoven, J. A. Swenberg, and R. G. Thurman
Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators
Carcinogenesis, January 1, 1999; 20(1): 27 - 33.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.